Page last updated: 2024-08-24

celgosivir and Viremia

celgosivir has been researched along with Viremia in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, KW; Dow, G; Low, JG; Ooi, EE; Vasudevan, SG; Watanabe, S	1
Aw, P; Chan, KW; Choy, MM; Connolly, JE; de Sessions, PF; Fan, L; Hibberd, ML; Kamaraj, US; Khoo, YM; Lee, B; Lee, HS; Low, JG; Ooi, EE; Rathore, AP; Sessions, OM; Sung, C; Vasudevan, SG; Vijaykrishna, D; Watanabe, S; Wei, Y; Wijaya, L	1
Flamand, M; Liu, W; Schul, W; Vasudevan, SG; Xu, HY	1

Trials

1 trial(s) available for celgosivir and Viremia

Article	Year
Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:8 Topics: Adult; Antiviral Agents; Cytokines; Dengue; Dengue Virus; Female; Half-Life; High-Throughput Nucleotide Sequencing; Humans; Indolizines; Male; Phylogeny; Th1 Cells; Viral Load; Viremia; Virus Replication	2016

Article

Year

Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients.

PLoS neglected tropical diseases, 2016, Volume: 10, Issue:8

Topics: Adult; Antiviral Agents; Cytokines; Dengue; Dengue Virus; Female; Half-Life; High-Throughput Nucleotide Sequencing; Humans; Indolizines; Male; Phylogeny; Th1 Cells; Viral Load; Viremia; Virus Replication

2016

Other Studies

2 other study(ies) available for celgosivir and Viremia

Article	Year
Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy. Antiviral research, 2016, Volume: 127 Topics: alpha-Glucosidases; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cricetinae; Cytokines; Dengue; Dengue Virus; Disease Models, Animal; Enzyme Inhibitors; Humans; In Vitro Techniques; Indolizines; Mice; Real-Time Polymerase Chain Reaction; Serogroup; Vero Cells; Viral Load; Viremia	2016
A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs. The Journal of infectious diseases, 2007, Mar-01, Volume: 195, Issue:5 Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Dengue; Disease Models, Animal; Dose-Response Relationship, Drug; Indolizines; Mice; Ribavirin; Time Factors; Tubercidin; Viremia; Virus Replication	2007

Article

Year

Optimizing celgosivir therapy in mouse models of dengue virus infection of serotypes 1 and 2: The search for a window for potential therapeutic efficacy.

Antiviral research, 2016, Volume: 127

Topics: alpha-Glucosidases; Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cricetinae; Cytokines; Dengue; Dengue Virus; Disease Models, Animal; Enzyme Inhibitors; Humans; In Vitro Techniques; Indolizines; Mice; Real-Time Polymerase Chain Reaction; Serogroup; Vero Cells; Viral Load; Viremia

2016

A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.

The Journal of infectious diseases, 2007, Mar-01, Volume: 195, Issue:5

Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Dengue; Disease Models, Animal; Dose-Response Relationship, Drug; Indolizines; Mice; Ribavirin; Time Factors; Tubercidin; Viremia; Virus Replication

2007